Multiple Myeloma Clinical Trials in Barcelona
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
- Multiple Myeloma
- Lemzoparlimab
- +4 more
- Tucson, Arizona
- +57 more
2022-04-06
Apr 6, 2022T
Active, not recruiting
- Multiple Myeloma
- Placebo
- Ixazomib
- Fountain Valley, California
- +277 more
2022-03-23
Mar 23, 2022G
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin frozen liquid
- Belantamab mafodotin lyophilized powder
- New Haven, Connecticut
- +58 more
2022-03-21
Mar 21, 2022J
J
Active, not recruiting
- Multiple Myeloma
- Dara SC
- Dara IV
- Boston, Massachusetts
- +145 more
2022-03-24
Mar 24, 2022J
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +6 more
- Southington, Connecticut
- +63 more
2022-03-24
Mar 24, 2022J
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +3 more
- Whittier, California
- +113 more
2022-03-24
Mar 24, 2022J
Recruiting
- Multiple Myeloma
- Bortezomib
- +5 more
- San Francisco, California
- +152 more
2022-03-24
Mar 24, 2022J
Active, not recruiting
- Multiple Myeloma
- Velcade
- +5 more
- California City, California
- +164 more
2022-03-24
Mar 24, 2022J
Active, not recruiting
- Multiple Myeloma
- JNJ-68284528
- +4 more
- Birmingham, Alabama
- +87 more
2022-03-24
Mar 24, 2022J
Recruiting
- Multiple Myeloma
- Carfilzomib 20 mg/m^2
- +4 more
- Gilbert, Arizona
- +113 more
2022-03-24
Mar 24, 2022J
J
Active, not recruiting
- Multiple Myeloma
- No intervention
- Tucson, Arizona
- +85 more
2022-03-24
Mar 24, 2022J
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
- Duarte, California
- +21 more
2022-03-24
Mar 24, 2022J
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +2 more
- Little Rock, Arkansas
- +145 more
2022-03-24
Mar 24, 2022G
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
- Birmingham, Alabama
- +31 more
2022-03-21
Mar 21, 2022G
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
- Yuma, Arizona
- +140 more
2022-03-18
Mar 18, 2022G
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
- Yuma, Arizona
- +35 more
2022-03-17
Mar 17, 2022G
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- Pom/dex (Pomalidomide plus low dose Dexamethasone)
- Tucson, Arizona
- +163 more
2022-02-25
Feb 25, 2022P
Recruiting
- Multiple Myeloma
- Non-eligible for Autologous Stem Cell Transplantation (ASCT)
- Arganda Del Rey, Spain
- +32 more
2022-03-08
Mar 8, 2022A
O
Terminated
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- +3 more
- Boston, Massachusetts
- +15 more
2022-03-04
Mar 4, 2022E
O
Terminated
- Relapse Multiple Myeloma
- Multiple Myeloma
- Melphalan Flufenamide
- +2 more
- Plovdiv, Bulgaria
- +25 more
2022-02-16
Feb 16, 2022H
Recruiting
- Multiple Myeloma in Relapse
- +3 more
- Gilbert, Arizona
- +16 more
2022-03-03
Mar 3, 2022